Month 00, 0000CSL delivered another strong year, with reported net profit after tax of $2,103 million, up
22
17% at CC and revenue up 9% at CC , reflecting;19 August 2020
o Solid growth in the immunoglobulin portfolio
o Successful evolution of haemophilia portfolio, driven by IDELVION®
o Transition to own distribution model in China
o Delivery on product differentiation strategy with strong profit growth forSeqirus
o No material revenue impact to-date resulting from the COVID-19 pandemic,however, the situation is fluid and some elements are unpredictableEarnings per share $4.63, up 17% at CC2
Final dividend3 of US$1.07 per share (approximately A$1.48)o Total full year dividend increased to US$2.02 per share, up 9%
o Converted to Australian currency, the total full year dividend is approximatelyA$2.95 per share, up 11%
Net profit after tax for FY21 is anticipated to be in the range of approximately $2,100million to $2,265 million at constant currencyo A key variable to this outlook is the uncertain impact of COVID-19 on theCompany’s supply chain, particularly the ability to collect plasma
o In response to the global pandemic, the Company urgently deployed itscapabilities, competencies and assets to support the global R&D effort, andnow has one vaccine partnership and four therapeutic candidates underinvestigation and development. Today’s profit outlook takes into account thisadditional research and development expense
- Forums
- ASX - By Stock
- CSL
- Ann: CSL Results Announcement
Ann: CSL Results Announcement, page-5
-
- There are more pages in this discussion • 117 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CSL (ASX) to my watchlist
(20min delay)
|
|||||
Last
$303.99 |
Change
0.890(0.29%) |
Mkt cap ! $147.1B |
Open | High | Low | Value | Volume |
$302.12 | $305.00 | $300.79 | $155.5M | 515.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 330 | $303.79 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$304.25 | 386 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 100 | 302.840 |
1 | 2 | 301.750 |
1 | 100 | 301.380 |
1 | 2 | 301.000 |
1 | 55 | 300.980 |
Price($) | Vol. | No. |
---|---|---|
304.650 | 70 | 1 |
304.810 | 21 | 1 |
305.000 | 2004 | 17 |
305.010 | 285 | 1 |
305.100 | 35 | 1 |
Last trade - 16.10pm 06/09/2024 (20 minute delay) ? |
Featured News
CSL (ASX) Chart |